首页 | 本学科首页   官方微博 | 高级检索  
检索        

消岩汤联合化疗对晚期非小细胞肺癌患者外周血VEGF的影响及其临床疗效
引用本文:朱津丽,张硕,张莹,李小江,贾英杰.消岩汤联合化疗对晚期非小细胞肺癌患者外周血VEGF的影响及其临床疗效[J].天津中医药,2020,37(1):38-43.
作者姓名:朱津丽  张硕  张莹  李小江  贾英杰
作者单位:天津中医药大学第一附属医院肿瘤科, 天津 300381,天津中医药大学第二附属医院, 天津 300250,天津中医药大学第一附属医院肿瘤科, 天津 300381,天津中医药大学第一附属医院肿瘤科, 天津 300381,天津中医药大学第一附属医院肿瘤科, 天津 300381
基金项目:天津市卫生和计划生育委员会中医药重点领域科研课题(2017003)。
摘    要:目的]观察消岩汤联合化疗对晚期非小细胞肺癌(NSCLC)患者外周血血管内皮生长因子(VEGF)的影响及其临床疗效。方法]将60例晚期NSCLC患者随机分2组:观察组(30例)予以GP方案化疗联合口服消岩汤治疗,对照组(30例)予以单纯化疗。2个化疗周期后,观察两组近期可观疗效、症状改善情况、生存质量的改善、血清VEGF含量变化以及毒副反应等指标。结果]消岩汤联合化疗,在稳定瘤体、提高患者的卡式评分、改善患者生活质量方面优于单纯化疗组,两组相比差异具有统计学意义,并且消岩汤联合化疗可以显著降低血清VEGF的含量,与单纯化疗相比差异具有统计学意义;在药物安全性方面,消岩汤能够明显降低化疗毒副作用,尤其是在白细胞减少、血红蛋白减少等血液毒性的改善方面有良好的临床疗效。结论]消岩汤与化疗联合能减轻晚期NSCLC的临床症状,提高功能状态评分(KPS),稳定病灶,并可抑制患者VEGF的表达,减轻造血系统的毒副反应,提高患者生活质量。

关 键 词:消岩汤  晚期非小细胞肺癌  化疗  血管生成  VEGF
收稿时间:2019/10/3 0:00:00

Effect and clinical efficacy of Xiaoyan Decoction combined with chemotherapy on peripheral blood vascular endothelial growth factor in patients with advanced non-small cell lung cancer
ZHU Jinli,ZHANG Shuo,ZHANG Ying,LI Xiaojiang and JIA Yingjie.Effect and clinical efficacy of Xiaoyan Decoction combined with chemotherapy on peripheral blood vascular endothelial growth factor in patients with advanced non-small cell lung cancer[J].Tianjin Journal of Traditional Chin Medicine,2020,37(1):38-43.
Authors:ZHU Jinli  ZHANG Shuo  ZHANG Ying  LI Xiaojiang and JIA Yingjie
Institution:Department of Oncology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300381, China,The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300250, China,Department of Oncology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300381, China,Department of Oncology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300381, China and Department of Oncology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300381, China
Abstract:Objective] To observe the effect of Xiaoyan Decoction combined with chemotherapy on peripheral blood vascular endothelial growth factor (VEGF) in patients with advanced non-small cell lung cancer (NSCLC) and its clinical efficacy.Methods] The 60 patients with advanced NSCLC were randomly divided into two groups:the observation group (30 cases) received GP regimen chemotherapy combined with oral Xiaoyan Decoction;the control group (30 cases) received chemotherapy alone. After two cycles of chemotherapy,the recent observable curative effect,improvement of symptoms,improvement of quality of life,changes of serum levels of vascular endothelial growth factor and toxic and side effects were observed.Results] Xiaoyan Decoction combined with chemotherapy was superior to chemotherapy alone in stabilizing tumors,improving patients'' chi-square scores and improving patients'' quality of life. The difference between the two groups was statistically significant. Moreover,Xiaoyan Decoction combined with chemotherapy could significantly reduce the serum level of vascular endothelial growth factor,which had significant difference compared with chemotherapy alone. In terms of drug safety,Xiaoyan Decoction could significantly reduce the toxic side effects of chemotherapy,especially in the reduction of leukopenia,hemoglobin and other hemotoxicity improvement has a good clinical effect.Conclusion] Xiaoyan Decoction combined with chemotherapy can alleviate the clinical symptoms of advanced NSCLC,improve KPS score,stabilize the lesion,inhibit the expression of vascular endothelial growth factor,alleviate the toxic side effects of hematopoietic system and improve the quality of life of patients.
Keywords:Xiaoyan Decoction  advanced NSCLC  chemotherapy  angiogenesis  VEGF
本文献已被 CNKI 等数据库收录!
点击此处可从《天津中医药》浏览原始摘要信息
点击此处可从《天津中医药》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号